Kelly M. Lohr, B.S. - Publications

Emory University, Atlanta, GA 
 Harvard University, Cambridge, MA, United States 
VMAT2, dopamine, Parkinson's disease

16/52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Sarkar S, Bardai F, Olsen AL, Lohr KM, Zhang YY, Feany MB. Oligomerization of Lrrk controls actin severing and α-synuclein neurotoxicity in vivo. Molecular Neurodegeneration. 16: 33. PMID 34030727 DOI: 10.1186/s13024-021-00454-3  0.76
2020 Lohr KM, Frost B, Scherzer C, Feany MB. Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model. Proceedings of the National Academy of Sciences of the United States of America. PMID 33318181 DOI: 10.1073/pnas.1922392117  0.76
2020 Branco RC, Burkett JP, Black CA, Winokur E, Elsworth W, Dhamsania RK, Lohr KM, Schroeder JP, Weinshenker D, Jovanovic T, Miller GW. Vesicular monoamine transporter 2 mediates fear behavior in mice. Genes, Brain, and Behavior. e12634. PMID 31898856 DOI: 10.1111/Gbb.12634  0.8
2017 Dunn AR, Stout KA, Ozawa M, Lohr KM, Hoffman CA, Bernstein AI, Li Y, Wang M, Sgobio C, Sastry N, Cai H, Caudle WM, Miller GW. Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 28246328 DOI: 10.1073/Pnas.1616892114  0.8
2016 Cliburn RA, Dunn AR, Stout KA, Hoffman CA, Lohr KM, Bernstein AI, Winokur EJ, Burkett J, Shmitz Y, Caudle WM, Miller GW. Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain. Journal of Chemical Neuroanatomy. PMID 27836486 DOI: 10.1016/J.Jchemneu.2016.11.003  0.8
2016 Lohr KM, Masoud ST, Salahpour A, Miller GW. Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. The European Journal of Neuroscience. PMID 27520881 DOI: 10.1111/Ejn.13357  0.8
2016 Stout KA, Dunn AR, Lohr KM, Alter SP, Cliburn RA, Guillot TS, Miller GW. Selective enhancement of dopamine release in the ventral pallidum of methamphetamine-sensitized mice. Acs Chemical Neuroscience. PMID 27501345 DOI: 10.1021/Acschemneuro.6B00131  0.8
2016 Lohr KM, Chen M, Hoffman CA, McDaniel MJ, Stout KA, Dunn AR, Wang M, Bernstein A, Miller GW. Vesicular monoamine transporter 2 (VMAT2) level regulates MPTP vulnerability and clearance of excess dopamine in mouse striatal terminals. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 27287315 DOI: 10.1093/Toxsci/Kfw106  0.8
2016 Trossbach SV, Bader V, Hecher L, Pum ME, Masoud ST, Prikulis I, Schäble S, de Souza Silva MA, Su P, Boulat B, Chwiesko C, Poschmann G, Stühler K, Lohr KM, Stout KA, et al. Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits. Molecular Psychiatry. PMID 26754951 DOI: 10.1038/Mp.2015.194  0.8
2015 Alter SP, Stout KA, Lohr KM, Taylor TN, Shepherd KR, Wang M, Guillot TS, Miller GW. Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration. Experimental Neurology. PMID 26428905 DOI: 10.1016/J.Expneurol.2015.09.016  0.8
2015 Coughlan C, Walker DI, Lohr KM, Richardson JR, Saba LM, Caudle WM, Fritz KS, Roede JR. Comparative Proteomic Analysis of Carbonylated Proteins from the Striatum and Cortex of Pesticide-Treated Mice. Parkinson's Disease. 2015: 812532. PMID 26345149 DOI: 10.1155/2015/812532  0.36
2015 Liu G, Sgobio C, Gu X, Sun L, Lin X, Yu J, Parisiadou L, Xie C, Sastry N, Ding J, Lohr KM, Miller GW, Mateo Y, Lovinger DM, Cai H. Selective Expression of Parkinson's disease-related Leucine-rich Repeat Kinase 2 G2019S Missense Mutation in Midbrain Dopaminergic Neurons Impairs Dopamine Release and Dopaminergic Gene Expression. Human Molecular Genetics. PMID 26123485 DOI: 10.1093/Hmg/Ddv249  0.8
2015 Lohr KM, Stout KA, Dunn AR, Wang M, Salahpour A, Guillot TS, Miller GW. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity. Acs Chemical Neuroscience. 6: 790-9. PMID 25746685 DOI: 10.1021/Acschemneuro.5B00010  0.8
2015 Coughlan C, Walker DI, Lohr KM, Richardson JR, Saba LM, Caudle WM, Fritz KS, Roede JR. Comparative proteomic analysis of carbonylated proteins from the striatum and cortex of pesticide-treated mice Parkinson's Disease. 2015. DOI: 10.1155/2015/812532  0.8
2014 Lohr KM, Miller GW. VMAT2 and Parkinson's disease: harnessing the dopamine vesicle. Expert Review of Neurotherapeutics. 14: 1115-7. PMID 25220836 DOI: 10.1586/14737175.2014.960399  0.8
2014 Lohr KM, Bernstein AI, Stout KA, Dunn AR, Lazo CR, Alter SP, Wang M, Li Y, Fan X, Hess EJ, Yi H, Vecchio LM, Goldstein DS, Guillot TS, Salahpour A, et al. Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America. 111: 9977-82. PMID 24979780 DOI: 10.1073/Pnas.1402134111  0.8
Low-probability matches
2021 Sarkar S, Olsen AL, Sygnecka K, Lohr KM, Feany MB. α-synuclein impairs autophagosome maturation through abnormal actin stabilization. Plos Genetics. 17: e1009359. PMID 33556113 DOI: 10.1371/journal.pgen.1009359  0.01
2015 Lohr KM, Clauser A, Hess BJ, Gelber AC, Valeriano-Marcet J, Lipner RS, Haist SA, Hawley JL, Zirkle S, Bolster MB. Performance on the Adult Rheumatology In-Training Examination and Relationship to Outcomes on the Rheumatology Certification Examination. Arthritis & Rheumatology (Hoboken, N.J.). 67: 3082-90. PMID 26215276 DOI: 10.1002/art.39281  0.01
2014 Daikh BE, Noss EH, Baer AN, Gall EP, Lohr KM, Maynard J, O'Neil KM, Ramirez A, Anderson L, Christenson M, Davidson I. Winners of the 2013 American college of rheumatology annual image competition Arthritis and Rheumatology. 66: 1070-1071. PMID 24777930 DOI: 10.1002/art.38575  0.01
2013 Kumar B, Toney DE, Alikhan M, Lohr KM. Giant cell arteritis presenting as depressed mood and headache in an elderly patient. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 19: 405-6. PMID 24048107 DOI: 10.1097/RHU.0b013e3182a701e8  0.01
2013 Chhakchhuak CL, Khosravi M, Lohr KM. Role of (18)F-FDG PET Scan in Rheumatoid Lung Nodule: Case Report and Review of the Literature. Case Reports in Rheumatology. 2013: 621340. PMID 23984160 DOI: 10.1155/2013/621340  0.01
2012 Niblock MM, Lohr KM, Nixon M, Barnes C, Schaudies M, Murphy M. Cells in the female retrotrapezoid region upregulate c-fos in response to 10%, but not 5%, carbon dioxide. Brain Research. 1433: 62-8. PMID 22137562 DOI: 10.1016/J.Brainres.2011.11.015  0.01
2011 Hardi L, DeCastro F, Lohr KM. Clinical images: Reticular rash in a patient with Wegener's granulomatosis. Arthritis and Rheumatism. 63: 861. PMID 21360516 DOI: 10.1002/art.30142  0.01
2011 Shen H, Xia L, Xiao W, Lu J, Hardi L, DeCastro F, Lohr KM. Increased levels of interleukin-27 in patients with rheumatoid arthritis Arthritis and Rheumatism. 63: 860-861. PMID 21360515 DOI: 10.1002/art.30180  0.01
2011 Baer AN, Daikh BE, Gall EP, Lohr KM, Maynard J, Noss EH, O'Neil KM, Ramirez A, Lee A, Baker N, Davidson I. Winners of the 2010 American College of Rheumatology Annual Image Competition Arthritis and Rheumatism. 63: 865-866. DOI: 10.1002/art.30268  0.01
2010 Baer AN, Daikh BE, Gall EP, Lohr KM, Maynard JW, Noss EH, O'Neil KM, Ramirez A, Wolpaw TM, Barr CJ, Kuchta G, Trizuto JL, Yung RL. Winners of the 2009 American College of rheumatology annual slide competition Arthritis and Rheumatism. 62: 915-916. DOI: 10.1002/art.27373  0.01
2008 Brown ML, Chesney PJ, Ault BH, Delos Santos NM, Truong LD, Lohr KM, Myers LK. Fever and rash. Clinical Pediatrics. 47: 610-4. PMID 18566359 DOI: 10.1177/0009922807312727  0.01
2002 Carbone LD, Lohr KM. Ethnic differences in male lupus. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 8: 239-40. PMID 17041376  0.01
2002 Navarro MJ, Higgins GC, Lohr KM, Myers LK. Amelioration of relapsing polychondritis in a child treated with oral collagen. The American Journal of the Medical Sciences. 324: 101-3. PMID 12187928  0.01
2002 Carbone LD, Lohr KM. Ethnic differences in male lupus [3] Journal of Clinical Rheumatology. 8: 239-240.  0.01
1999 McKown KM, Carbone LD, Kaplan SB, Aelion JA, Lohr KM, Cremer MA, Bustillo J, Gonzalez M, Kaeley G, Steere EL, Somes GW, Myers LK, Seyer JM, Kang AH, Postlethwaite AE. Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis. Arthritis and Rheumatism. 42: 1204-8. PMID 10366113 DOI: 10.1002/1529-0131(199906)42:6<1204::AID-ANR17>3.0.CO;2-U  0.01
1998 Lohr KM. Women in science Scientist. 12.  0.01
1995 McKown KM, Lohr KM. Pseudothrombophlebitis in neuropathic arthropathy of the shoulder. Southern Medical Journal. 88: 377. PMID 7886544  0.01
1994 McKown KM, Lohr KM. Pseudothrombophlebitis in neuropathic arthropathy of the shoulder. Southern Medical Journal. 87: 845-7. PMID 8052901  0.01
1994 Sprabery AT, Newman K, Lohr KM. Aortic mural thrombus presenting as pseudovasculitis. Chest. 106: 282-3. PMID 7912661  0.01
1994 Odhav S, McKown K, Lohr KM. Polyarteritis nodosa presenting as recurrent myocardial infarction. Chest. 105: 1615. PMID 7910132  0.01
1990 Lohr KM, Kurth CA, Xie DL, Seyer JM, Homandberg GA. The amino-terminal 29- and 72-Kd fragments of fibronectin mediate selective monocyte recruitment. Blood. 76: 2117-24. PMID 2242430  0.01
1988 Lohr KM, Engbring NH. Institution-wide program for impaired residents at a major teaching hospital. Journal of Medical Education. 63: 182-8. PMID 3346894  0.01
1988 Lohr KM, Ryan LM, Toohill RJ, Anderson T. Anterior pituitary involvement in Wegener's granulomatosis. The Journal of Rheumatology. 15: 855-7. PMID 3172100  0.01
1987 Lohr KM, Barthelemy CR, Schwab JP, Haasler GB. Septic spondylodiscitis in ankylosing spondylitis. The Journal of Rheumatology. 14: 616-20. PMID 3625646  0.01
1987 Lohr KM. Rheumatic manifestations of diseases associated with substance abuse. Seminars in Arthritis and Rheumatism. 17: 90-111. PMID 3334286 DOI: 10.1016/0049-0172(87)90032-1  0.01
1986 Ripple RE, Lohr KM, Twining SS, Hyndiuk RA, Caya JG. Role of leukocytes in ocular inflammation of tyrosinemia II. Investigative Ophthalmology & Visual Science. 27: 926-31. PMID 3519521  0.01
1986 Twining SS, Lohr KM, Moulder JE. The immune system in experimental Pseudomonas keratitis. Model and early effects. Investigative Ophthalmology & Visual Science. 27: 507-15. PMID 3082789  0.01
1985 Lohr KM, Hyndiuk RA, Hatchell DL, Kurth CE. Corneal organ cultures in tyrosinemia release chemotactic factors. The Journal of Laboratory and Clinical Medicine. 105: 573-80. PMID 2580925  0.01
1984 Lohr KM. Precipitation of hyperosmolar nonketotic diabetes on alternate-day corticosteroid therapy. Jama. 252: 628. PMID 6737666 DOI: 10.1001/jama.1984.03350050020016  0.01
1984 Lohr KM, Feix JB, Kurth C. Chlorpromazine inhibits neutrophil chemotaxis beyond the chemotactic receptor-ligand interaction. The Journal of Infectious Diseases. 150: 643-52. PMID 6092486  0.01
1982 Lohr KM, Snyderman R. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes. Journal of Immunology (Baltimore, Md. : 1950). 129: 1594-9. PMID 6286769  0.01
1982 Lohr KM, Snyderman R. Alteration of neutrophil chemotactic factor receptor affinity and biological activities by amphotericin B (AmB) Clinical Research. 30: 373A.  0.01
1982 Lohr KM, Kurth C, Feix J. Effect of chlorpromazine on the human neutrophil chemotactic factor receptor and membrane fluidity Clinical Research. 30: 739A.  0.01
1981 Lohr KM, Snyderman R. Disorders of human leukocyte chemotaxis. Clinical Immunology Reviews. 1: 67-118. PMID 6762275  0.01
1981 Lohr KM, Synderman R. Effects of amphotericin B (AmB) on chemotactic peptide-mediated neutrophil functions Clinical Research. 29: 783A.  0.01
1981 Lohr KM, Snyderman R. Effects of amphotericin B on a human neutrophil chemotactic factor receptor Federation Proceedings. 40: 761.  0.01
Hide low-probability matches.